Lilani Perera, MD, AGAF
Associate Professor (appointment pending)
Boston University Chobanian & Avedisian School of Medicine
Medicine
Gastroenterology




Dr. Lilani Perera is a distinguished gastroenterologist specializing in inflammatory bowel disease (IBD) and serving as the Director of the Crohn’s & Colitis Program at Boston Medical Center. She is also an Associate Clinical Professor of Medicine at Boston University. Dr. Perera graduated with honors from the University of Colombo, completed her fellowships in gastroenterology at Medical College of Wisconsin and IBD immunology research fellowship at Mount Sinai Medical Center, NY. Her career includes significant roles at the Medical College of Wisconsin, Advocate Aurora Health, and Tufts Medical Center, where she developed comprehensive IBD programs. She is actively involved in national organizations like the American Gastroenterological Association and the Crohn's and Colitis Foundation, focusing on patient education and gender equity. Dr. Perera has a robust research background with numerous publications and is dedicated to mentoring future healthcare professionals. Her leadership and contributions have been recognized through prestigious programs, establishing her as a leader in gastroenterology.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Perera L. Patient Resource Spotlight: Biosimilars: What You Should Know Webpage. Gastroenterol Hepatol (N Y). 2023 Mar; 19(3):130. PMID: 37706106; PMCID: PMC10496282
     
  2. Raffals LE, Saha S, Bewtra M, Norris C, Dobes A, Heller C, O'Charoen S, Fehlmann T, Sweeney S, Weaver A, Bishu S, Cross R, Dassopoulos T, Fischer M, Yarur A, Hudesman D, Parakkal D, Duerr R, Caldera F, Korzenik J, Pekow J, Wells K, Bohm M, Perera L, Kaur M, Ciorba M, Snapper S, Scoville EA, Dalal S, Wong U, Lewis JD. The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Inflamm Bowel Dis. 2022 Feb 01; 28(2):192-199. PMID: 34436563; PMCID: PMC9013198; DOI: 10.1093/ibd/izab071;
     
  3. Perera LP, Radigan M, Guilday C, Banerjee I, Eastwood D, Babygirija R, Massey BT. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression. Dig Dis Sci. 2019 Jul; 64(7):1923-1928. PMID: 30725303; DOI: 10.1007/s10620-019-05488-8;
     
  4. Perera LP, Bhandari S, Liu R, Guilday C, Zadvornova Y, Saeian K, Eastwood D. Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease. Dig Dis Sci. 2018 Jul; 63(7):1787-1793. PMID: 29713985; DOI: 10.1007/s10620-018-5076-6;
     
  5. Szigethy EM, Allen JI, Reiss M, Cohen W, Perera LP, Brillstein L, Cross RK, Schwartz DA, Kosinski LR, Colton JB, LaRusso E, Atreja A, Regueiro MD. White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):986-997. PMID: 28300693; DOI: 10.1016/j.cgh.2017.02.037;
     
  6. Perera LP, Ananthakrishnan AN, Guilday C, Remshak K, Zadvornova Y, Naik AS, Stein DJ, Massey BT. Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission. Dig Dis Sci. 2013 Dec; 58(12):3600-5. PMID: 24026401; DOI: 10.1007/s10620-013-2850-3;
     
  7. Bautista MC, Otterson MF, Zadvornova Y, Naik AS, Stein DJ, Venu N, Perera LP. Surgical outcomes in the elderly with inflammatory bowel disease are similar to those in the younger population. Dig Dis Sci. 2013 Oct; 58(10):2955-62. PMID: 23836319; DOI: 10.1007/s10620-013-2754-2;
     
  8. Ananthakrishnan AN, Zadvornova Y, Naik AS, Issa M, Perera LP. Impact of pregnancy on health-related quality of life of patients with inflammatory bowel disease. J Dig Dis. 2012 Sep; 13(9):472-7. PMID: 22908973; DOI: 10.1111/j.1751-2980.2012.00618.x;
     
  9. Qumseya BJ, Ananthakrishnan AN, Skaros S, Bonner M, Issa M, Zadvornova Y, Naik A, Perera L, Binion DG. QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States. Inflamm Bowel Dis. 2011 Jan; 17(1):77-83. PMID: 20848501; DOI: 10.1002/ibd.21329;
     
  10. Ananthakrishnan AN, Beaulieu DB, Ulitsky A, Zadvornova Y, Skaros S, Johnson K, Naik A, Perera L, Issa M, Binion DG, Saeian K. Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? Inflamm Bowel Dis. 2010 Mar; 16(3):494-500. PMID: 19637332; DOI: 10.1002/ibd.21051;
     
Showing 10 of 15 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 15 publications over 13 distinct years, with a maximum of 2 publications in 2009 and 2013

YearPublications
20061
20071
20081
20092
20101
20111
20121
20132
20171
20181
20191
20221
20231

Contact for Mentoring:

Perera's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (112) concept(s)
_
Similar People
See all (60) people
_
Same Department
Search Department